Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Lam, Hieu"'
Autor:
Jensen-Pergakes K; Oncology Research Division, Pfizer Inc.; San Diego, California., Tatlock J; Oncology Medicinal Chemistry, Pfizer Inc.; San Diego, California., Maegley KA; Oncology Research Division, Pfizer Inc.; San Diego, California., McAlpine IJ; Oncology Medicinal Chemistry, Pfizer Inc.; San Diego, California., McTigue M; Oncology Medicinal Chemistry, Pfizer Inc.; San Diego, California., Xie T; Oncology Research Division, Pfizer Inc.; San Diego, California., Dillon CP; Oncology Research Division, Pfizer Inc.; San Diego, California., Wang Y; Oncology Research Division, Pfizer Inc.; San Diego, California., Yamazaki S; Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., San Diego, California., Spiegel N; Oncology Research Division, Pfizer Inc.; San Diego, California., Shi M; Oncology Research Division, Pfizer Inc.; San Diego, California., Nemeth A; Oncology Research Division, Pfizer Inc.; San Diego, California., Miller N; Oncology Research Division, Pfizer Inc.; San Diego, California., Hendrickson E; Oncology Research Division, Pfizer Inc.; San Diego, California., Lam H; Oncology Research Division, Pfizer Inc.; San Diego, California., Sherrill J; Oncology Research Division, Pfizer Inc.; San Diego, California., Chung CY; Oncology Research Division, Pfizer Inc.; San Diego, California., McMillan EA; Oncology Research Division, Pfizer Inc.; San Diego, California., Bryant SK; Oncology Research Division, Pfizer Inc.; San Diego, California., Palde P; Oncology Research Division, Pfizer Inc.; San Diego, California., Braganza J; Oncology Medicinal Chemistry, Pfizer Inc.; San Diego, California., Brooun A; Oncology Medicinal Chemistry, Pfizer Inc.; San Diego, California., Deng YL; Oncology Medicinal Chemistry, Pfizer Inc.; San Diego, California., Goshtasbi V; Oncology Medicinal Chemistry, Pfizer Inc.; San Diego, California., Kephart SE; Oncology Medicinal Chemistry, Pfizer Inc.; San Diego, California., Kumpf RA; Oncology Medicinal Chemistry, Pfizer Inc.; San Diego, California., Liu W; Oncology Medicinal Chemistry, Pfizer Inc.; San Diego, California., Patman RL; Oncology Medicinal Chemistry, Pfizer Inc.; San Diego, California., Rui E; Oncology Medicinal Chemistry, Pfizer Inc.; San Diego, California., Scales S; Oncology Medicinal Chemistry, Pfizer Inc.; San Diego, California., Tran-Dube M; Oncology Medicinal Chemistry, Pfizer Inc.; San Diego, California., Wang F; Oncology Medicinal Chemistry, Pfizer Inc.; San Diego, California., Wythes M; Oncology Medicinal Chemistry, Pfizer Inc.; San Diego, California., Paul TA; Oncology Research Division, Pfizer Inc.; San Diego, California. Thomas.A.Paul@pfizer.com.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2022 Jan; Vol. 21 (1), pp. 3-15. Date of Electronic Publication: 2021 Nov 04.
Autor:
Chen P; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, San Diego, California., Lee NV; Oncology Research Unit, Pfizer Worldwide Research and Development, San Diego, California., Hu W; Drug Safety, Pfizer Worldwide Research and Development, San Diego, California., Xu M; Oncology Research Unit, Pfizer Worldwide Research and Development, San Diego, California., Ferre RA; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, San Diego, California., Lam H; Oncology Research Unit, Pfizer Worldwide Research and Development, San Diego, California., Bergqvist S; Oncology Research Unit, Pfizer Worldwide Research and Development, San Diego, California., Solowiej J; Oncology Research Unit, Pfizer Worldwide Research and Development, San Diego, California., Diehl W; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, San Diego, California., He YA; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, San Diego, California., Yu X; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, San Diego, California., Nagata A; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, San Diego, California., VanArsdale T; Oncology Research Unit, Pfizer Worldwide Research and Development, San Diego, California., Murray BW; Oncology Research Unit, Pfizer Worldwide Research and Development, San Diego, California. brion.murray@pfizer.com.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2016 Oct; Vol. 15 (10), pp. 2273-2281. Date of Electronic Publication: 2016 Aug 05.